| Soleo Health Inc Pho | |
| 415 S 48th St, Ste 101, Tempe, Arizona 85281 | |
| (480) 296-0222 |
| Name | Soleo Health Inc Pho |
|---|---|
| Organization Name | Soleo Health Inc |
| Location | 415 S 48th St, Ste 101, Tempe, Arizona 85281 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (480) 296-0222 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The combination of traditional chemotherapy agents with targeted therapies called monoclonal antibodies showed no safety concerns and improved survival in patients with advanced non-small cell lung cancer according to a study presented at the 2008 Chicago Multidisciplinary Symposium in Thoracic Oncology, sponsored by ASTRO, ASCO, IASLC and the University of Chicago.
H. Lundbeck A/S and Otsuka Pharmaceutical Co., Ltd. announced today the continuation of the development program of Lu AE58054 for the treatment of Alzheimer's disease, initiating the first out of four phase III clinical trials with the compound.
Dr. Jayant Patel, 60, is pleading not guilty to the manslaughter of Mervyn Morris, Gerry Kemps and James Phillips and grievous bodily harm to Ian Vowles during his time as director of surgery at the Bundaberg Base Hospital between 2003 and 2005. In new developments the Brisbane Supreme Court heard many medical specialists give evidence against Patel's decision to operate on Mr. Phillips in May 2003 who later died.
People with Alzheimer's disease experience a rate of cognitive decline four times greater than those with no cognitive impairment according to a new study by researchers at Rush University Medical Center in Chicago.
XenoPort, Inc. announced today preliminary top-line results from a Phase 2b clinical trial of arbaclofen placarbil (also known as AP) as adjunctive therapy in patients with gastroesophageal reflux disease (GERD) who do not experience complete relief of GERD symptoms while being treated with proton pump inhibitors (PPI).
› Verified 6 days ago
| NPI Number | 1104230176 |
| Organization Name | SOLEO HEALTH INC. |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 415 S 48th St, Suite 101, Tempe, AZ 85281 |
| Phone Number | 480-296-0222 |
News Archive
The combination of traditional chemotherapy agents with targeted therapies called monoclonal antibodies showed no safety concerns and improved survival in patients with advanced non-small cell lung cancer according to a study presented at the 2008 Chicago Multidisciplinary Symposium in Thoracic Oncology, sponsored by ASTRO, ASCO, IASLC and the University of Chicago.
H. Lundbeck A/S and Otsuka Pharmaceutical Co., Ltd. announced today the continuation of the development program of Lu AE58054 for the treatment of Alzheimer's disease, initiating the first out of four phase III clinical trials with the compound.
Dr. Jayant Patel, 60, is pleading not guilty to the manslaughter of Mervyn Morris, Gerry Kemps and James Phillips and grievous bodily harm to Ian Vowles during his time as director of surgery at the Bundaberg Base Hospital between 2003 and 2005. In new developments the Brisbane Supreme Court heard many medical specialists give evidence against Patel's decision to operate on Mr. Phillips in May 2003 who later died.
People with Alzheimer's disease experience a rate of cognitive decline four times greater than those with no cognitive impairment according to a new study by researchers at Rush University Medical Center in Chicago.
XenoPort, Inc. announced today preliminary top-line results from a Phase 2b clinical trial of arbaclofen placarbil (also known as AP) as adjunctive therapy in patients with gastroesophageal reflux disease (GERD) who do not experience complete relief of GERD symptoms while being treated with proton pump inhibitors (PPI).
› Verified 6 days ago
| NPI Number | 1528511425 |
| Organization Name | SOLEO HEALTH INC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 415 S 48th Street, Suite 101, Tempe, AZ 85281 |
| Phone Number | 480-296-0222 |
News Archive
The combination of traditional chemotherapy agents with targeted therapies called monoclonal antibodies showed no safety concerns and improved survival in patients with advanced non-small cell lung cancer according to a study presented at the 2008 Chicago Multidisciplinary Symposium in Thoracic Oncology, sponsored by ASTRO, ASCO, IASLC and the University of Chicago.
H. Lundbeck A/S and Otsuka Pharmaceutical Co., Ltd. announced today the continuation of the development program of Lu AE58054 for the treatment of Alzheimer's disease, initiating the first out of four phase III clinical trials with the compound.
Dr. Jayant Patel, 60, is pleading not guilty to the manslaughter of Mervyn Morris, Gerry Kemps and James Phillips and grievous bodily harm to Ian Vowles during his time as director of surgery at the Bundaberg Base Hospital between 2003 and 2005. In new developments the Brisbane Supreme Court heard many medical specialists give evidence against Patel's decision to operate on Mr. Phillips in May 2003 who later died.
People with Alzheimer's disease experience a rate of cognitive decline four times greater than those with no cognitive impairment according to a new study by researchers at Rush University Medical Center in Chicago.
XenoPort, Inc. announced today preliminary top-line results from a Phase 2b clinical trial of arbaclofen placarbil (also known as AP) as adjunctive therapy in patients with gastroesophageal reflux disease (GERD) who do not experience complete relief of GERD symptoms while being treated with proton pump inhibitors (PPI).
› Verified 6 days ago
News Archive
The combination of traditional chemotherapy agents with targeted therapies called monoclonal antibodies showed no safety concerns and improved survival in patients with advanced non-small cell lung cancer according to a study presented at the 2008 Chicago Multidisciplinary Symposium in Thoracic Oncology, sponsored by ASTRO, ASCO, IASLC and the University of Chicago.
H. Lundbeck A/S and Otsuka Pharmaceutical Co., Ltd. announced today the continuation of the development program of Lu AE58054 for the treatment of Alzheimer's disease, initiating the first out of four phase III clinical trials with the compound.
Dr. Jayant Patel, 60, is pleading not guilty to the manslaughter of Mervyn Morris, Gerry Kemps and James Phillips and grievous bodily harm to Ian Vowles during his time as director of surgery at the Bundaberg Base Hospital between 2003 and 2005. In new developments the Brisbane Supreme Court heard many medical specialists give evidence against Patel's decision to operate on Mr. Phillips in May 2003 who later died.
People with Alzheimer's disease experience a rate of cognitive decline four times greater than those with no cognitive impairment according to a new study by researchers at Rush University Medical Center in Chicago.
XenoPort, Inc. announced today preliminary top-line results from a Phase 2b clinical trial of arbaclofen placarbil (also known as AP) as adjunctive therapy in patients with gastroesophageal reflux disease (GERD) who do not experience complete relief of GERD symptoms while being treated with proton pump inhibitors (PPI).
› Verified 6 days ago
Nielsen And Cyment, Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2403 W Huntington Dr, Tempe, Arizona 85282 Phone: (480) 675-9122 | |
Preferred Homecare Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3280 S Country Club Way, Tempe, Arizona 85282 Phone: (480) 505-0038 | |
Cvs Pharmacy #09205 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 802 S Mill Ave, Tempe, Arizona 85281 Phone: (480) 966-6271 | |
Cvs Pharmacy #05950 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 855 E Elliot Rd, Tempe, Arizona 85284 Phone: (480) 456-3602 | |
Cvs Pharmacy #07078 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3303 S Rural Rd, Tempe, Arizona 85282 Phone: (480) 345-6328 |